According to a recent report by Precedence Research, the global in vitro diagnostics (IVD) market is projected to reach approximately USD 124.65 billion by 2032, witnessing a substantial increase from USD 107.76 billion in 2023....
Addressing the growing burden of sepsis in China using PCR-based diagnostic assays...
Roche announced the launch of the Elecsys®Anti-HEV IgM and Elecsys Anti-HEV IgG immunoassays for the detection of hepatitis E virus (HEV) infections in countries accepting the CE mark. By testing for HEV infection, clinicians can support their patients to identify the cause of their symptoms and determine appropriate treatment, monitor for progression to severe acute HEV and prevent severe disease progression with antiviral treatment.1,2,6...
Introduces advanced PHI processing capability at its National Reference Lab, Noida...
GE HealthCare a collaboration with Novo Nordisk to further advance the clinical and product development of peripheral focused ultrasound (PFUS). This is a novel technology that has potential to specifically regulate metabolic function in the body using ultrasound that may support the treatment of chronic diseases such as type 2 diabetes and obesity....
Healthcare localization and standardization support the Belt and Road Initiative...
Fapon will support Halodoc in local IVD product research and manufacturing...
Nearly 50% of American adults living with diabetes will be affected by diabetic neuropathy complications in their lifetime...
Roche announced new data from the Phase II FENopta study showing that investigational, oral fenebrutinib is brain penetrant and reduces brain lesions in people with relapsing multiple sclerosis (RMS) with a consistent safety profile to other fenebrutinib trials. The late-breaking data were featured in an oral presentation at the 9th Joint ECTRIMS-ACTRIMS Meeting (European and Americas Committees for Treatment and Research in Multiple Sclerosis)....
To identify patients with the MSI biomarker who may be eligible for potential treatment with Jemperli ...
